
浏览全部资源
扫码关注微信
1.710068 西安, 陕西省人民医院: 胸外科
2.710048 西安, 陕西省新安中心医院妇产科
3.710068 西安, 陕西省人民医院: 呼吸内科
任睿, E-mail: cyf.521@qq.com Ren Rui, E-mail: cyf.521@qq.com
纸质出版日期:2017-1-30,
收稿日期:2016-7-18,
录用日期:2016-9-7
扫 描 看 全 文
曹燕飞, 任睿, 杨晔, 等. miR-185通过调控E2F6抑制肺鳞癌细胞增殖和侵袭[J]. 第三军医大学学报, 2017,39(2):123-129.
Yanfei Cao, Rui Ren, Ye Yang, et al. MicroRNA-185 inhibits proliferation and invasion of lung squamous cells
曹燕飞, 任睿, 杨晔, 等. miR-185通过调控E2F6抑制肺鳞癌细胞增殖和侵袭[J]. 第三军医大学学报, 2017,39(2):123-129. DOI: 10.16016/j.1000-5404.201607118.
Yanfei Cao, Rui Ren, Ye Yang, et al. MicroRNA-185 inhibits proliferation and invasion of lung squamous cells
目的
2
探讨微小RNA-185(microRNA-185, miR-185)对肺鳞癌细胞增殖和侵袭能力的作用及其可能的作用机制。
方法
2
人肺鳞癌细胞系(NCI-H520、NCI-H226)以及正常肺上皮细胞(BEAS-2B)为实验用细胞; qRT-PCR检测miR-185表达量;miR-NC(对照)和miR-185 mimics(miR-185类似物)利用Turbofect进行转染;Western blot检测E2F6的蛋白表达量;双荧光素酶报告基因检测miR-185与E2F6的靶向调控关系;MTT检测细胞的增殖能力;细胞侵袭试剂盒检测细胞的侵袭能力;构建pcDNA.3.1-E2F6重组载体,并转染肺鳞癌细胞过表达E2F6。
结果
2
miR-185表达量在肺鳞癌细胞中显著降低(
P
<0.01)。miR-185靶向抑制E2F6基因(
P
<0.05)。转染miR-185 mimics显著上调miR-185的细胞含量(
P
<0.01)并抑制E2F6蛋白表达(
P
<0.01),肺鳞癌细胞增殖能力(
P
<0.05或
P
<0.01)和侵袭能力(
P
<0.05)亦显著受抑。转染pcDNA.3.1-E2F6到miR-185含量升高的细胞,E2F6蛋白表达量显著升高(
P
<0.01)且细胞增殖 (
P
<0.01)和侵袭能力(
P
<0.05)上升。
结论
2
miR-185可以通过靶向E2F6抑制肺鳞癌细胞增殖和侵袭。
Objective
2
To determine the effect of microRNA-185 (miR-185) on the proliferation and invasion of lung squamous cells and investigate the possible underlying mechanism.
Methods
2
Human lung squamous cancer cell lines (NCI-H520 and NCI-H226) and normal lung cell line (BEAS-2B) were used in the research. The miR-185 expression was detected by quantitative real-time PCR (qRT-PCR) in the above cells. The targeted relationship between miR-185 and E2F6 was detected by dual luciferase reporter assay. After MiRNA-NC and miR-185 mimics were transfected into the cells by using Turbofect
the protein expression of E2F6 was measured by Western blot assay
cell proliferation was detected by MTT assay
and cells invasion was measured by cell invasion kit. pcDNA.3.1-E2F6 recombinant plasmid was constructed
and transfected into lung squamous cells to over-express E2F6.
Results
2
miR-185 expression was significantly decreased in the lung squamous cells (
P
<0.01). miR-185 directly targeted E2F6 gene (
P
<0.05). miR-185 mimics transfection markedly up-regulated the content of miR-185 (
P
<0.01) and inhibited the protein expression of E2F6 (
P
<0.01)
and obviously suppressed the cell proliferation (
P
<0.05 or
P
<0.01) and invasion (
P
<0.05) of lung squamous cells. Transfection of pcDNA.3.1-E2F6 resulted in the over-expression of miR-185
the up-regulation of E2F6 protein (
P
<0.01)
and thus significantly promoted the cell proliferation (
P
<0.01) and invasion (
P
<0.05).
Conclusion
2
miR-185 inhibits the proliferation and invasion of the lung squamous cells
via
targeting E2F6.
肺鳞癌miR-185E2F6增殖侵袭
squamous cell lung carcinomamiR-185E2F6proliferationinvasion
Janne P A, Yang J C, Kim D W, et al. AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer[J]. N Engl J Med, 2015, 372(18): 1689-1699. DOI: 10.1056/NEJMoa1411817
Leidinger P, Backes C, Blatt M, et al. The blood-borne miRNA signature of lung cancer patients is independent of histology but influenced by metastases[J]. Mol Cancer, 2014, 13(1): 202. DOI: 10.1186/1476-4598-13-202
Cheng H, Shcherba M, Kandavelou K, et al. Emerging drugs for squamous cell lung cancer[J]. Expert Opin Emerg Drugs, 2015, 20(1): 149-160. DOI: 10.1517/14728214.2015.1001365
Dini Modigliani S, Morlando M, Errichelli L, et al. An ALS-associated mutation in the FUS 3′-UTR disrupts a microRNA-FUS regulatory circuitry[J]. Nat Commun, 2014, 5:4335. DOI: 10.1038/ncomms5335
Gruber A R, Martin G, Muller P, et al. Global 3′ UTR shortening has a limited effect on protein abundance in proliferating T cells[J]. Nat Commun, 2014, 5:5465. DOI: 10.1038/ncomms6465
Zhou P, Xu W, Peng X, et al. Large-scale screens of miRNA-mRNA interactions unveiled that the 3′UTR of a gene is targeted by multiple miRNAs[J]. PLoS One, 2013, 8(7): e68204. DOI: 10.1371/journal.pone.0068204
Takahashi Y, Forrest A R, Maeno E, et al. miR-107 and miR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines[J]. PLoS One, 2009, 4(8): e6677. DOI: 10.1371/journal.pone.0006677
Tang H, Liu P, Yang L, et al. miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer[J]. Mol Cancer Ther, 2014, 13(12): 3185-3197. DOI: 10.1158/1535-7163.MCT-14-0243
Lortet-Tieulent J, Soerjomataram I, Ferlay J, et al. International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women[J]. Lung Cancer, 2014, 84(1): 13-22. DOI: 10.1016/j.lungcan.2014.01.009
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359-386. DOI: 10.1002/ijc.29210
Li Y, Zhou Y, Wang H. Research status on molecular targeted therapy for squamous-cell lung cancer[J]. Zhongguo Fei Ai Za Zhi, 2014, 17(8): 618-624. DOI: 10.3779/j.issn.1009-3419.2014.08.07
Gurtan A M, Sharp P A. The role of miRNAs in regulating gene expression networks[J]. J Mol Biol, 2013, 425(19): 3582-3600. DOI: 10.1016/j.jmb.2013.03.007
Carpenter S, Ricci E P, Mercier B C, et al. Post-transcriptional regulation of gene expression in innate immunity[J]. Nat Rev Immunol, 2014, 14(6): 361-376. DOI: 10.1038/nri3682
Lee H Y, Mohammed K A, Kaye F, et al. Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer[J]. Int J Nanomedicine, 2013, 8: 4481-4494. DOI: 10.2147/IJN.S41782
Campayo M, Navarro A, Vinolas N, et al. Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer[J]. Eur Respir J, 2013, 41(5): 1172-1178. DOI: 10.1183/09031936.00048712
Begum S, Hayashi M, Ogawa T, et al. An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation[J]. Sci Rep, 2015, 5: 13236. DOI: 10.1038/srep13236
Li J, Yang H, Li Y, et al. microRNA-146 up-regulation predicts the prognosis of non-small cell lung cancer by miRNA in situ hybridization[J]. Exp Mol Pathol, 2014, 96(2): 195-199. DOI: 10.1016/j.yexmp.2013.11.004
Li S, Ma Y, Hou X, et al. miR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells[J]. Int J Clin Exp Pathol, 2015, 8(9): 11854-11862.
Qu F, Cui X, Hong Y, et al. MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor[J]. Mol Cell Biochem, 2013, 377(1/2): 121-130. DOI: 10.1007/s11010-013-1576-z
Lu Z J, Lu L G, Tao K Z, et al. MicroRNA-185 suppresses growth and invasion of colon cancer cells through inhibition of the hypoxiainducible factor-2alpha pathway in vitro and in vivo[J]. Mol Med Rep, 2014, 10(5): 2401-2408. DOI: 10.3892/mmr.2014.2562
Liu M, Lang N, Chen X, et al. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells[J]. Cancer Lett, 2011, 301(2): 151-160. DOI: 10.1016/j.canlet.2010.11.009
Li Q, Qiu X M, Li Q H, et al. MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7[J]. Oncol Rep, 2015, 33(5): 2354-2360. DOI: 10.3892/or.2015.3812
Leseva M, Santostefano K E, Rosenbluth A L, et al. E2f6-mediated repression of the meiotic Stag3 and Smc1beta genes during early embryonic development requires Ezh2 and not the de novo methyltransferase Dnmt3b[J]. Epigenetics, 2013, 8(8): 873-884. DOI: 10.4161/epi.25522
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621